(S)-Ibrutinib, the S-enantiomer of ibrutinib, is an irreversible and highly selective Btk (Brutons tyrosine kinase) inhibitor with anticancer activity. Ibrutinib (PCI-32765; trade nameImbruvica) is an approved anticancer medication.

纯度：≥98%

CAS：936563-97-2